Buy SPRAVATO (esketamine) online

Buy Spravato esketamine nasal spray online in New Zealand and Australia

• Generic Name: esketamine nasal spray
• Brand Name: Spravato

What is SPRAVATO and how is it used?

Spravato is a prescription medicine used to treat the symptoms of Treatment-resistant Depression and Major Depressive Disorder. Spravato may be used alone or with other medications.

Spravato belongs to a class of drugs called Antidepressants, Other; NMDA Antagonists.

It is not known if Spravato is safe and effective in children. Buy Spravato esketamine nasal spray online in New Zealand and Australia

INDICATIONS

SPRAVATO^® is indicated, in conjunction with an oral antidepressant, for the treatment of:

• Treatment-resistant depression (TRD) in adults
• Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior

Limitations Of Use

• The effectiveness of SPRAVATO in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated [see Clinical Studies]. Use of SPRAVATO does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO.
• SPRAVATO is not approved as an anesthetic agent. The safety and effectiveness of SPRAVATO as an anesthetic agent have not been established. Buy Spravato esketamine nasal spray online in New Zealand and Australia

DOSAGE AND ADMINISTRATION

Important Considerations Prior To Initiating And During Therapy

SPRAVATO must be administered under the direct supervision of a healthcare provider. A treatment session consists of nasal administration of SPRAVATO and post-administration observation under supervision. Buy Spravato esketamine nasal spray online in New Zealand and Australia

Blood Pressure Assessment Before And After Treatment

• Assess blood pressure prior to dosing with SPRAVATO [see WARNINGS AND PRECAUTIONS].
• If baseline blood pressure is elevated (e.g., >140 mmHg systolic, >90 mmHg diastolic), consider the risks of short term increases in blood pressure and benefit of SPRAVATO treatment [see WARNINGS AND PRECAUTIONS]. Do not administer SPRAVATO if an increase in blood pressure or intracranial pressure poses a serious risk [see CONTRAINDICATIONS].
• After dosing with SPRAVATO, reassess blood pressure at approximately 40 minutes (which corresponds with the Cmax) and subsequently as clinically warranted.
• If blood pressure is decreasing and the patient appears clinically stable for at least two hours, the patient may be discharged at the end of the post-dose monitoring period; if not, continue to monitor [see WARNINGS AND PRECAUTIONS]. Buy Spravato esketamine nasal spray online in New Zealand and Australia

Food And Liquid Intake Recommendations Prior To Administration

Because some patients may experience nausea and vomiting after administration of SPRAVATO [see ADVERSE REACTIONS], advise patients to avoid food for at least 2 hours before administration and to avoid drinking liquids at least 30 minutes prior to administration.

Nasal Corticosteroid Or Nasal Decongestant

Patients who require a nasal corticosteroid or nasal decongestant on a dosing day should administer these medications at least 1 hour before SPRAVATO [see CLINICAL PHARMACOLOGY]. Buy Spravato esketamine nasal spray online in New Zealand and Australia

Treatment-Resistant Depression

Administer SPRAVATO in conjunction with an oral antidepressant (AD).

The recommended dosage of SPRAVATO for the treatment of TRD in adults is shown in Table 1. Dosage adjustments should be made based on efficacy and tolerability. Evidence of therapeutic benefit should be evaluated at the end of the induction phase to determine need for continued treatment.